Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (51-60 of 350) with videos related to

Pageof 35
Sort By:
International Journal of Cancer|April 5, 2013
BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancerDavid Capper, Anita Voigt, Gergana Bozukova, et al.
Acta Neuropathologica|February 26, 2013
Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cellsChristian Koelsche, Adelheid Wöhrer, Astrid Jeibmann, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 23, 2015
Validation of a Manual Protocol for BRAF V600E Mutation-specific ImmunohistochemistryHanns C Dinges, David Capper, Olga Ritz, et al.
Acta Neuropathologica|November 12, 2010
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphologyDavid Capper, David Reuss, Jens Schittenhelm, et al.
Neuro-Oncology Practice|April 26, 2021
FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in gliomaJens Schittenhelm, Lukas Ziegler, Jan Sperveslage, et al.
Neuropathology and Applied Neurobiology|December 3, 2014
BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cystsLeonille Schweizer, David Capper, Annett Hölsken, et al.
Nature Methods|March 12, 2022
A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolutionTianyu Zhu, Jacklyn Liu, Stephan Beck, et al.
Journal of Neuro-Oncology|June 27, 2016
Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysisChristine Jungk, Moritz Scherer, Andreas Mock, et al.
The American Journal of Surgical Pathology|May 18, 2012
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinomaOskar Koperek, Christoph Kornauth, David Capper, et al.
Human Pathology|October 19, 2015
Synchronous pituitary adenoma and pituicytomaMarian C Neidert, Henning Leske, Jan-Karl Burkhardt, et al.
Pageof 35

Showing results (51-60 of 350) with videos related to

Sort By:
Pageof 35
International Journal of Cancer|April 5, 2013
BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancerDavid Capper, Anita Voigt, Gergana Bozukova, et al.
Acta Neuropathologica|February 26, 2013
Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cellsChristian Koelsche, Adelheid Wöhrer, Astrid Jeibmann, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 23, 2015
Validation of a Manual Protocol for BRAF V600E Mutation-specific ImmunohistochemistryHanns C Dinges, David Capper, Olga Ritz, et al.
Acta Neuropathologica|November 12, 2010
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphologyDavid Capper, David Reuss, Jens Schittenhelm, et al.
Neuro-Oncology Practice|April 26, 2021
FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in gliomaJens Schittenhelm, Lukas Ziegler, Jan Sperveslage, et al.
Neuropathology and Applied Neurobiology|December 3, 2014
BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cystsLeonille Schweizer, David Capper, Annett Hölsken, et al.
Nature Methods|March 12, 2022
A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolutionTianyu Zhu, Jacklyn Liu, Stephan Beck, et al.
Journal of Neuro-Oncology|June 27, 2016
Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysisChristine Jungk, Moritz Scherer, Andreas Mock, et al.
The American Journal of Surgical Pathology|May 18, 2012
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinomaOskar Koperek, Christoph Kornauth, David Capper, et al.
Human Pathology|October 19, 2015
Synchronous pituitary adenoma and pituicytomaMarian C Neidert, Henning Leske, Jan-Karl Burkhardt, et al.
Pageof 35